Inhaler

Patients with asthma preferred convenient management options that prioritized decreases in short-term morbidity over long-term goals, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Electronic monitoring devices supported short-term adherence to asthma medication, with sustained improvements in asthma control, according to an abstract presented at the European Respiratory Society International Congress.

Healio has compiled the most-read news in pulmonology posted in August.

Inhaler technique often worsens within 12 months of instruction, with many patients experiencing deterioration in technique 1 to 3 months after instruction, according to a recent study.

Glycopyrronium/indacaterol reduced the likelihood for severe acute exacerbations and cardiovascular events compared with tiotropium/olodaterol among patients with COPD, according to study results published in CHEST.

Inhaler technique deteriorates within 12 months of clinical instruction among patients with asthma and COPD, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.

Generic fluticasone-salmeterol demonstrated similar safety and effectiveness as the brand-name version among patients with chronic obstructive pulmonary disease, according to researchers.

Patients with COPD and cognitive impairment had heightened odds for inaccurate use of their inhaler 1 month after receiving training, according to study results published in BMC Pulmonary Medicine.

A long-acting muscarinic antagonist plus long-acting beta agonist (LABA) was linked to fewer COPD exacerbations and pneumonia hospitalizations vs. an inhaled corticosteroid and LABA, according to results published in JAMA Internal Medicine.

Gov. Phil Murphy of New Jersey has signed legislation that will cap monthly out-of-pocket prescription costs for epinephrine autoinjectors at $25 and asthma inhalers at $50 in all state-regulated and public employee health insurance plans.